Mr. Buten has more than 20 years of experience in healthcare investing as well as 15 years as an advisor in investment banking and strategic structuring of deals for both small and large capitalization companies. In 2021, he joined Biohaven Pharmaceuticals as Chief Financial Officer. Prior to Biohaven, he served as managing director of Foresite Capital Management for nearly a decade. Mr. Buten’s prior roles include healthcare portfolio manager at Catapult Capital Management LLC / Millennium LP, co-founder and co-manager of Sapphire Capital Partners LLP, a co-founder and a partner at Argus Partners, a Managing Director and Head of Healthcare Investment Banking for Needham & Company, LLC, and Director in Investment Banking at Smith Barney Inc. He holds a B.S. in Economics from The Wharton School of the University of Pennsylvania.